The Personalized Immunotherapy Research Lab (PIRL)

PIRL is a multi-PI lab at the University of North Carolina at Chapel Hill that works on discovering and optimizing the therapeutic components needed to turn antigen-directed immunotherapies into a broadly effective treatment for cancer. Learn more on our lab website.

Subscribe